| Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States L Chen, DR Nelson, Y Zhao, Z Cui, JA Johnston BMC geriatrics 13 (1), 1-8, 2013 | 237 | 2013 |
| Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's Y Zhao, TC Kuo, S Weir, MS Kramer, AS Ash BMC health services research 8 (1), 1-8, 2008 | 224 | 2008 |
| Predicting pharmacy costs and other medical costs using diagnoses and drug claims Y Zhao, AS Ash, RP Ellis, JZ Ayanian, GC Pope, B Bowen, L Weyuker Medical care, 34-43, 2005 | 173 | 2005 |
| Evaluating the economic burden of psoriasis in the United States J Vanderpuye-Orgle, Y Zhao, J Lu, A Shrestha, A Sexton, S Seabury, ... Journal of the American Academy of Dermatology 72 (6), 961-967. e5, 2015 | 150 | 2015 |
| Finding future high-cost cases: comparing prior cost versus diagnosis-based methods. AS Ash, Y Zhao, RP Ellis, MS Kramer Health services research 36 (6 Pt 2), 194, 2001 | 144 | 2001 |
| Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Y Zhao, RP Ellis, AS Ash, D Calabrese, JZ Ayanian, JP Slaughter, ... Health services research 36 (6 Pt 2), 180, 2001 | 115 | 2001 |
| Implications of comorbidity on costs for patients with Alzheimer disease TC Kuo, Y Zhao, S Weir, MS Kramer, AS Ash Medical care, 839-846, 2008 | 103 | 2008 |
| A meta‐analysis of pain response in the treatment of fibromyalgia NS Roskell, SM Beard, Y Zhao, TK Le Pain practice 11 (6), 516-527, 2011 | 91 | 2011 |
| Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA NJ Korman, Y Zhao, J Pike, J Roberts Clinical and experimental dermatology 41 (5), 514-521, 2016 | 89 | 2016 |
| Economic and comorbidity burden among moderate‐to‐severe psoriasis patients with comorbid psoriatic arthritis SR Feldman, Y Zhao, L Shi, MH Tran, J Lu Arthritis care & research 67 (5), 708-717, 2015 | 84 | 2015 |
| Economic and comorbidity burden among patients with moderate-to-severe psoriasis SR Feldman, Y Zhao, L Shi, MH Tran Journal of managed care & specialty pharmacy 21 (10), 874-888, 2015 | 72 | 2015 |
| Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy Y Zhao, W Ye, KS Boye, JH Holcombe, JA Hall, R Swindle Journal of Diabetes and its Complications 24 (1), 9-19, 2010 | 70 | 2010 |
| Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis SR Feldman, Y Zhao, P Navaratnam, HS Friedman, J Lu, MH Tran Journal of managed care & specialty pharmacy 21 (3), 201-209, 2015 | 69 | 2015 |
| Disease burden profiles: an emerging tool for managing managed care Y Zhao, AS Ash, RP Ellis, JP Slaughter Health care management science 5 (3), 211-219, 2002 | 68 | 2002 |
| Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona … B Strober, JD Greenberg, C Karki, M Mason, N Guo, P Hur, Y Zhao, ... BMJ open 9 (4), e027535, 2019 | 62 | 2019 |
| Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity NJ Korman, Y Zhao, J Pike, J Roberts, E Sullivan Dermatology online journal 21 (10), 2015 | 58 | 2015 |
| A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients L Boulanger, Y Zhao, Y Bao, MW Russell BMC health services research 9 (1), 111, 2009 | 56 | 2009 |
| Health service utilization among Alzheimer's disease patients: evidence from managed care JR Frytak, HJ Henk, Y Zhao, L Bowman, JA Flynn, M Nelson Alzheimer's & Dementia 4 (5), 361-367, 2008 | 51 | 2008 |
| Secukinumab improves patient‐reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo‐controlled clinical trials B Strober, B Sigurgeirsson, G Popp, R Sinclair, J Krell, S Stonkus, ... International journal of dermatology 55 (4), 401-407, 2016 | 43 | 2016 |
| Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials A Blauvelt, H Sofen, K Papp, M Gooderham, S Tyring, Y Zhao, S Lowry, ... Journal of the European Academy of Dermatology and Venereology 33 (12), 2305 …, 2019 | 42 | 2019 |
